Diffuse brainstem glioma in children: critical review of clinical trials

The Lancet Oncology
Darren HargraveEric Bouffet

Abstract

Diffuse intrinsic brainstem gliomas constitute 15-20% of all CNS tumours in children, and are the main cause of death in children with brain tumours. Many clinical trials have been done over the past three decades, but survival has remained static. More than 90% of children die within 2 years of diagnosis, and conventional fractionated radiation remains the standard treatment. However, median survival differs substantially between clinical trials, suggesting a survival benefit with some strategies. We appraised the consistency between protocols in terms of eligibility criteria, definition and assessment of response and progression, statistical design, and endpoints. Study designs varied substantially, which could explain the differences in outcome, and no treatment has shown a benefit over conventional radiotherapy. However, consistency between protocols (eg, eligibility criteria and outcome measures) is important to measure the progress in management of diffuse pontine gliomas.

References

Jun 1, 1992·Child's Nervous System : ChNS : Official Journal of the International Society for Pediatric Neurosurgery·B PakischH Leitner
Aug 1, 1988·International Journal of Radiation Oncology, Biology, Physics·C R FreemanD Norris
Apr 30, 1995·International Journal of Radiation Oncology, Biology, Physics·M D PradosV A Levin
Jun 1, 1994·International Journal of Epidemiology·C A Stiller, J Nectoux
Sep 10, 1998·Journal of the National Cancer Institute·M A SmithR Simon
Oct 31, 2000·Radiotherapy and Oncology : Journal of the European Society for Therapeutic Radiology and Oncology·D Schulz-ErtnerM Wannenmacher

❮ Previous
Next ❯

Citations

Aug 12, 2008·Child's Nervous System : ChNS : Official Journal of the International Society for Pediatric Neurosurgery·U W ThomaleG I Jallo
Mar 11, 2010·Child's Nervous System : ChNS : Official Journal of the International Society for Pediatric Neurosurgery·Kuo-Liang ChiangTai-Tong Wong
May 3, 2011·Child's Nervous System : ChNS : Official Journal of the International Society for Pediatric Neurosurgery·Soumen KhatuaJohn R W Kestle
Jan 28, 2012·Child's Nervous System : ChNS : Official Journal of the International Society for Pediatric Neurosurgery·Guifa XiStewart Goldman
Dec 12, 2012·Child's Nervous System : ChNS : Official Journal of the International Society for Pediatric Neurosurgery·Rejin KebudiEmin Darendeliler
May 15, 2013·Child's Nervous System : ChNS : Official Journal of the International Society for Pediatric Neurosurgery·Tene A CageNalin Gupta
Apr 10, 2012·Brain Tumor Pathology·Hidehiro OkaKiyotaka Fujii
Jul 4, 2012·Brain Tumor Pathology·Maysa Al-HussainiSameh Hashem
Jul 1, 2008·Journal of Neuro-oncology·Robert M HaywardKatherine E Warren
May 14, 2011·Journal of Neuro-oncology·Emilie A Steffen-SmithKatherine E Warren
Jan 11, 2012·Journal of Neuro-oncology·Yasuyuki AokiNalin Gupta
Dec 13, 2012·Journal of Neuro-oncology·Zhiping ZhouMark M Souweidane
Jul 3, 2013·Journal of Neuro-oncology·Sadhana JacksonAlberto Broniscer
Oct 13, 2006·Current Treatment Options in Oncology·Jaishri O Blakeley, Stuart A Grossman
Mar 21, 2013·Current Neurology and Neuroscience Reports·Sean A Grimm, Marc C Chamberlain
Feb 27, 2013·Current Treatment Options in Neurology·Jane E Minturn, Michael J Fisher
Jan 19, 2013·Paediatric Drugs·Trent R HummelDavid Franz
May 31, 2013·Paediatric Drugs·Rejin Kebudi, Fatma Betul Cakir
Jun 30, 2009·Neurotherapeutics : the Journal of the American Society for Experimental NeuroTherapeutics·Sabine Mueller, Susan Chang
Apr 16, 2009·Molecular Therapy : the Journal of the American Society of Gene Therapy·Gregory K FriedmanG Yancey Gillespie
Oct 27, 2010·Neuro-oncology·Birgit GeoergerUNKNOWN ITCC (Innovative Therapies for Children with Cancer) European Consortium
Jun 4, 2011·Neuro-oncology·Christof M KrammJohannes E Wolff
Jul 21, 2011·Neuro-oncology·Stefan BlümlFloyd H Gilles
Jul 26, 2011·Neuro-oncology·T J MacDonaldC M Kramm
Oct 9, 2008·Current Opinion in Oncology·Florence Laigle-DonadeyJean-Yves Delattre
Dec 24, 2013·Current Opinion in Pediatrics·Pamela Kearns, Bruce Morland
Oct 28, 2008·Journal of Child Neurology·Debbie K Song, Russell R Lonser
Oct 28, 2008·Journal of Child Neurology·Nicholas G Gottardo, Amar Gajjar
Oct 6, 2010·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Alberto BroniscerAmar Gajjar
Sep 21, 2011·Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology·Barbara S PaughSuzanne J Baker
Nov 16, 2007·Neuro-oncology·Ashok PanigrahyStefan Blüml
Nov 12, 2009·Future Oncology·Catherine LamUte Bartels
Jan 15, 2011·Journal of Nuclear Medicine : Official Publication, Society of Nuclear Medicine·Katherine A ZukotynskiTina Young Poussaint
Jul 5, 2011·Journal of Neurosurgery. Pediatrics·Todd C HankinsonMichael H Handler
Dec 3, 2011·Journal of Neurosurgery. Pediatrics·Frederick A Boop

❮ Previous
Next ❯

Related Concepts

Related Feeds

Cancer Stem Cells in Glioblastoma

Glioblastoma is the most common and aggressive type of brain tumor. It contains a population of tumor initiating stem cell-like cells known as cancer stem cells. Investigations are ongoing into these cancer stem cells found in these solid tumors which are highly resistance to treatment. Here is the latest research on cancer stem cells in glioblastoma.